Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

BACKGROUND: Cardiovascular comorbidity is common among patients with chronic obstructive pulmonary disease (COPD) and there is concern that long-acting bronchodilators (long-acting muscarinic antagonists (LAMAs) and long-acting beta(2) agonists (LABAs)) may further increase the risk of acute coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkin, Lianne, Williams, Sheila, Barson, David, Sharples, Katrina, Horsburgh, Simon, Jackson, Rod, Dummer, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839854/
https://www.ncbi.nlm.nih.gov/pubmed/33495233
http://dx.doi.org/10.1136/bmjresp-2020-000840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839854/
https://www.ncbi.nlm.nih.gov/pubmed/33495233
http://dx.doi.org/10.1136/bmjresp-2020-000840

Ejemplares similares